Jan 19, 2018 / 14:15
Vietnam maintains double-digit growth in pharmaceutical imports
Vietnam has spent more than VND63 trillion (US$2.7 billion) on pharmaceutical imports in 2017, up 10% from the previous year.
While pharmaceutical import has maintained a two-digit increase for many consecutive years, the imports of pharmaceutical raw materials have slightly decreased, data from the General Department of Customs showed.
Most of Vietnam’s pharmaceutical supply markets are European countries. France and Germany are the two largest markets with turnovers of US$342 million and US$316 million, respectively, accounting for over 23% of the total. It’s noteworthy that imports from India, Vietnam’s third largest suppliers, grew exponentially to 40 times the volume of the same period in 2016.
Insufficient resources to invent new drugs and the limited number of businesses with technology meeting the high standards of the EU’s Good Manufacturing Practices (GMP) or Pharmaceutical Inspection Co-operation Scheme (PIC/S) are the main cause of the sharp increase in pharmaceutical imports in recent years, according to a report by market research firm Business Monitor International (BMI).
With limited manufacturing capability, Vietnam has to import 55% of drugs it needs every year. In 2016, Vietnam imported US$2.5 billion worth of drugs, data from BMI showed.
In 2017, domestic sales were expected to reach US$5.2 billion, an increase of about 10% over a year earlier, and expected to maintain a double-digit growth over the next five years, according to BMI.
Imports of pharmaceutical products increased from US$2.035 million in 2014 to US$2.32 billion in 2015 and US$2.563 billion in 2016. Vietnamese pharmaceutical market is showing a positive growth with estimated revenues of US$5.2 billion last year, up 10%, and is forecast to achieve double-digit growth over the next five years.
Vietnam maintains double-digit growth in pharmaceutical imports.
|
Insufficient resources to invent new drugs and the limited number of businesses with technology meeting the high standards of the EU’s Good Manufacturing Practices (GMP) or Pharmaceutical Inspection Co-operation Scheme (PIC/S) are the main cause of the sharp increase in pharmaceutical imports in recent years, according to a report by market research firm Business Monitor International (BMI).
With limited manufacturing capability, Vietnam has to import 55% of drugs it needs every year. In 2016, Vietnam imported US$2.5 billion worth of drugs, data from BMI showed.
In 2017, domestic sales were expected to reach US$5.2 billion, an increase of about 10% over a year earlier, and expected to maintain a double-digit growth over the next five years, according to BMI.
Imports of pharmaceutical products increased from US$2.035 million in 2014 to US$2.32 billion in 2015 and US$2.563 billion in 2016. Vietnamese pharmaceutical market is showing a positive growth with estimated revenues of US$5.2 billion last year, up 10%, and is forecast to achieve double-digit growth over the next five years.
Other News
- Applying digital transformation to foster reading culture
- "Denmark in Your Eyes Contest: Youth networking for a green future
- National language celebrated by Vietnamese community in South Korea
- Hanoi accelerating efforts to reduce new tuberculosis cases
- Hanoi tackles overcrowded classrooms
- Vietnamese journalists get expertise from Indian experts
- Effective STEM education in Hanoi schools
- Vietnamese students' skills recognized in PISA survey
- Hanoi aims for 94.5% health insurance coverage this year.
- Denmark helps Vietnam enhance primary health care
Trending
-
Hanoi flowers on postage stamps
-
French market awaits Vietnamese green, sustainable businesses
-
Tech giants pay nearly US$580 million in taxes in Vietnam
-
Carnaval Ha Long 2024 woos tourists with fireworks and drone light shows
-
Affordable, quality tours offered at Hanoi Tourism Festival 2024
-
Introduction of community tourism area in Hanoi herb kingdom
-
Capital Law revision helps Hanoi promote role as nation’s socio-economic hub
-
IT training urged to focus on semiconductors
-
Voluntary social security should cover larger part of informal sector: Experts